Pharmacist's Letter Canada | Convenient Monthly Updates + CE

May 2026 Issue

Answer Questions About the Ringza Contraceptive Vaginal Ring

Ringza (ethinyl estradiol/segesterone) will be a new long-term vaginal contraceptive ring that will compete with NuvaRing...

Resources

Chart: Canada: Comparison of Oral Contraceptives and Non-Oral Alternatives

Understand the Place in Therapy of Delafloxacin

Delafloxacin (Baxdela) is a new oral and IV quinolone antibiotic...

Help Optimize Treatment of Dyslipidemia in Children

More children will get screened and treated for dyslipidemia...

Use Evidence to Clear up Questions About Gabapentin

Patients are asking more questions about gabapentin claims from social media, from family and friends, etc...

GO TO FULL ISSUE

CE & Training

INTERACTIVE SELF-STUDY CE: GLP-1 Agonists: Supporting Success with Nutrition and Lifestyle Considerations

CE-IN-THE-LETTER: Pharmacist's Letter Canada May 2026

LIVE CE: Pharmacy Essential Updates May 2026

PODCAST CE: Medication Talk - GLP-1 Agonists: Clinical Conundrums

GO TO CE & TRAINING ORGANIZER >

Featured Clinical Resources

GLP-1 and GIP/GLP-1 Receptor Agonists interactive chart

Inhalation Medications for Asthma (Canada)

Stepwise Treatment of Asthma j12 Years and Older

Group Purchases & Pricing

Pharmacist’s Letter Canada is eligible for bulk discounts. Easily manage staff access and customize CE & training assignments. Bundle with other products for significant savings. Request information